Ovarian cancer drug approved for NHS use will prolong lives

Patient.info·Jun 10

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A new drug for ovarian cancer has been approved for use by the NHS, with reports suggesting it will prolong lives. The drug is intended for advanced or chemotherapy-resistant cases of the disease. It is described as the first major breakthrough in ovarian cancer treatment in 20 years, with hundreds of women potentially benefiting from the new treatment.

Full coverage

Fetching the latest headlines…

Ovarian cancer drug approved for NHS use will prolong lives

Full coverage

Life-prolonging drug for advanced ovarian cancer gets go-ahead in England

New Life-Extending Drug for Women with Ovarian Cancer

Treatment for chemotherapy-resistant ovarian cancer approved for NHS use

First ovarian cancer treatment in 20 years approved for NHS use

NHS rolls out life-extending drug for hundreds of women with ovarian cancer

New ‘life-extending’ drug for ovarian cancer added to NHS

New ovarian cancer drug approved on NHS in first major breakthrough in 20 years

NHS rolls out first new ovarian cancer drug in 20 years